t3_1gp81g4

CDC reports slight flu rise in children, first kid's flu death of season

t3_1gp6dp1

These updated recommendations also allow for flexibility for additional doses (i.e., three or more) for those who are moderately or severely immunocompromised, in consultation with their healthcare provider (a strategy known as shared clinical decision making).

The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults and those who are immunocompromised, along with the currently available data on vaccine effectiveness and year-round circulation of COVID-19. The recommendation also provides clarity to healthcare providers on how many doses should be given per year to people who are moderately or severely immunocompromised and is meant to increase coverage of this second dose for that group.

Data continues to confirm the importance of vaccination to protect those most at risk for severe outcomes of COVID-19. Receiving recommended 2024-2025 COVID-19 vaccines can restore and enhance protection against the virus variants currently responsible for most infections and hospitalizations in the United States. COVID-19 vaccination also reduces the chance of suffering the effects of Long COVID, which can develop during or following acute infection and last for an extended duration.

CDC and ACIP will continue to monitor COVID-19 vaccine safety and effectiveness. CDC continues to recommend that everyone stay up to date on their COVID-19 vaccines, especially people ages 65 years and older and those with weakened immune systems.

<div class="md"><p>These updated recommendations also allow for flexibility for additional doses (i.e., three or more) for those who are moderately or severely immunocompromised, in consultation with their healthcare provider (a strategy known as shared clinical decision making).</p>

<p>The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults and those who are immunocompromised, along with the currently available data on vaccine effectiveness and year-round circulation of COVID-19. The recommendation also provides clarity to healthcare providers on how many doses should be given per year to people who are moderately or severely immunocompromised and is meant to increase coverage of this second dose for that group.</p>

<p>Data continues to confirm the importance of vaccination to protect those most at risk for severe outcomes of COVID-19. Receiving recommended 2024-2025 COVID-19 vaccines can restore and enhance protection against the virus variants currently responsible for most infections and hospitalizations in the United States. COVID-19 vaccination also reduces the chance of suffering the effects of Long COVID, which can develop during or following acute infection and last for an extended duration.</p>

<p>CDC and ACIP will continue to monitor COVID-19 vaccine safety and effectiveness. CDC continues to recommend that everyone stay up to date on their COVID-19 vaccines, especially people ages 65 years and older and those with weakened immune systems.</p>
</div>

CDC Recommends 2nd Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised: These updated recommendations also allow for flexibility for additional doses (i.e., three or more) for those...

t3_1gool5n

Bay Area counties renew mask mandates at health care facilities - starting on November 1 and continuing through March 31, 2025.

t3_1gom8my

Study finds child immunization program helped combat meningitis and blood poisoning

t3_1gohidj

Beyond preventing shingles: Epidemiology researcher leads $1.7M study on Shingrix’s impact on dementia, stroke in nursing homes | UDaily

t3_1go9vtt

HPV vaccination: How the world can eliminate cervical cancer - Our World in Data

t3_1gnvwfi

WHO study lists top endemic pathogens for which new vaccines are urgently needed

t3_1gno41a

First presumptive positive case of H5 avian influenza detected in B.C.

t3_1gnob48

t3_1gnfppf

More at the link;


>COVID-19 Vaccines With Additional Dose Recommendations 

>Everyone 6 months or older is recommended to receive a dose of the updated 2024-2025 COVID vaccine. An additional updated COVID vaccine dose is now recommended for everyone aged 65 or older, and for those aged 6 months or older with immunocompromising (moderate or severe) conditions. Review of data revealed that 1 in 6 patients hospitalized with COVID have an immunocompromising condition, and 70% of COVID hospitalizations are in those aged 65 or older. This older age group also has the highest death rates due to COVID-19. We know that vaccination protection wanes with time. Data from previous studies show that additional vaccine doses provide additional protection. Additional doses are now being recommended for those at highest risk.

>Timing of additional doses. This second dose is recommended at 6 months after the last updated COVID-19 vaccine dose. However, the additional dose can be given as early as 2 months after the last dose. Those who recently had COVID-19 can wait 3 months before getting an additional vaccine dose. This flexibility allows patients to maximize additional protection by timing additional doses around travel and life events, such as weddings, family get-togethers, or chemotherapy.

>Those with immunocompromising conditions may receive more doses. **Patients with immunocompromising conditions can receive even more additional doses, if recommended by their physician, under shared clinical decision-making.**

<div class="md"><p>More at the link;</p>

<blockquote>
<p>COVID-19 Vaccines With Additional Dose Recommendations </p>

<p>Everyone 6 months or older is recommended to receive a dose of the updated 2024-2025 COVID vaccine. An additional updated COVID vaccine dose is now recommended for everyone aged 65 or older, and for those aged 6 months or older with immunocompromising (moderate or severe) conditions. Review of data revealed that 1 in 6 patients hospitalized with COVID have an immunocompromising condition, and 70% of COVID hospitalizations are in those aged 65 or older. This older age group also has the highest death rates due to COVID-19. We know that vaccination protection wanes with time. Data from previous studies show that additional vaccine doses provide additional protection. Additional doses are now being recommended for those at highest risk.</p>

<p>Timing of additional doses. This second dose is recommended at 6 months after the last updated COVID-19 vaccine dose. However, the additional dose can be given as early as 2 months after the last dose. Those who recently had COVID-19 can wait 3 months before getting an additional vaccine dose. This flexibility allows patients to maximize additional protection by timing additional doses around travel and life events, such as weddings, family get-togethers, or chemotherapy.</p>

<p>Those with immunocompromising conditions may receive more doses. <strong>Patients with immunocompromising conditions can receive even more additional doses, if recommended by their physician, under shared clinical decision-making.</strong></p>
</blockquote>
</div>

Fall Vaccine Updates From ACIP: New Recs

t3_1gmtumw

Moderna says COVID/flu shot clears phase 3 hurdle: onsists of components of mRNA-1010, Moderna’s vaccine candidate for seasonal influenza, and mRNA-1283, its next-generation bivalent COVID-19 vaccine, which targets updated variants of SARS-CoV-2 and can be stored in a refrigerator

How do people die of the flu? In the last decade, there have been between 21,000 and 51,000 deaths from flu each season (USA)

How Public Health Could Be Recast in a Second Trump Term

Bird flu infects 1 in 14 dairy workers exposed; CDC urges better protections

Doctors report first U.S. cases of sexually transmitted ringworm rash

VA marks millionth COVID case as officials warn health threat persists

CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older - Merck.com

Recent COVID-19 vaccination tied to lower risk of long COVID

Novavax, UK terminate vaccine supply agreement

Flu deaths high in hospitalized elderly, up to 30 days after discharge, new data show: Medical providers should be aware of the residual risk for mortality soon after discharge from an influenza-associated hospitalization, particularly among older adults.

Quick takes: UK reports 4th clade 1b mpox case, more avian flu in US cows and poultry, UK raises H5 risk level

Scientists develop test to better track whooping cough strains amid outbreak in Australia: in 2024, there have been more than 10 times the number of cases compared to the whole of 2023, with children aged 9 to 12 accounting for nearly 40% of all notified cases

New Study Reveals How Repeated mRNA Vaccines Boost Nasal Immunity Against COVID-19

WHO identifies priority pathogens for new vaccines development

Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk | GSK Canada

We can do more to reduce influenza deaths among older Canadians: it is a common cause of pneumonia, and together flu and pneumonia are the eighth-leading cause of death in Canada

First Human Case of Tularemia Confirmed in Boulder County in 2024

[https://www.npr.org/sections/goats-and-soda/2024/11/01/g-s1-30948/virus-marburg-outbreak-rwanda-unprecedented-success](An 'unprecedented' good news story about a potentially deadly viral outbreak)

<div class="md"><p>[<a href="https://www.npr.org/sections/goats-and-soda/2024/11/01/g-s1-30948/virus-marburg-outbreak-rwanda-unprecedented-success%5D(An">https://www.npr.org/sections/goats-and-soda/2024/11/01/g-s1-30948/virus-marburg-outbreak-rwanda-unprecedented-success](An</a> &#39;unprecedented&#39; good news story about a potentially deadly viral outbreak)</p>
</div>

A 22.7% fatality rate for Rwandan Marburg outbreak- a disease that usually kills 90% of patients

USDA will launch testing of bulk raw milk for bird flu contamination

Low COVID, flu vaccine uptake noted in US healthcare workers

The cat of researcher John Lednicky Ph.D caught a mouse and he took it to his lab to look for mule deer pox. Instead...

>[the mouse, caught by a cat] "harbored a jeilongvirus, previously found in Africa, Asia, Europe, and South America. It comes from a family of viruses that infect mammals, reptiles, birds, and fish, and can occasionally cause serious illness in humans.And this wasn’t just any jeilongvirus. It’s genetically much different from other jeilongviruses"

>“It grows equally well in rodent, human, and nonhuman primate (monkey) cells, making it a great candidate for a spillover event,”

>"Jeilongviruses are not yet well understood, but they are a type of paramyxovirus, which are associated with respiratory infections. While the finding that Gainesville rodent jeilong virus 1 can infect many different species is troubling, DeRuyter said, there is no need to panic. Most humans have little direct contact with jeilongviruses’ main host, wild rats and mice. Take for example, hantavirus, another virus found in wild rodents."

>“Humans can develop severe to fatal illness if they get infected by hantaviruses, but so far, those types of infections remain rare and typically occur only among people who come into contact with rodent waste, often through airborne exposure to rodent urine or fecal material,”


<div class="md"><p>The cat of researcher John Lednicky Ph.D caught a mouse and he took it to his lab to look for mule deer pox. Instead...</p>

<blockquote>
<p>[the mouse, caught by a cat] &quot;harbored a jeilongvirus, previously found in Africa, Asia, Europe, and South America. It comes from a family of viruses that infect mammals, reptiles, birds, and fish, and can occasionally cause serious illness in humans.And this wasn’t just any jeilongvirus. It’s genetically much different from other jeilongviruses&quot;</p>

<p>“It grows equally well in rodent, human, and nonhuman primate (monkey) cells, making it a great candidate for a spillover event,”</p>

<p>&quot;Jeilongviruses are not yet well understood, but they are a type of paramyxovirus, which are associated with respiratory infections. While the finding that Gainesville rodent jeilong virus 1 can infect many different species is troubling, DeRuyter said, there is no need to panic. Most humans have little direct contact with jeilongviruses’ main host, wild rats and mice. Take for example, hantavirus, another virus found in wild rodents.&quot;</p>

<p>“Humans can develop severe to fatal illness if they get infected by hantaviruses, but so far, those types of infections remain rare and typically occur only among people who come into contact with rodent waste, often through airborne exposure to rodent urine or fecal material,”</p>
</blockquote>
</div>

UF scientists discover first jeilongvirus in the U.S., thanks to a cat - UF Health

Infectious Disease News is about any current outbreaks, scientific publications, cases, media stories, press releases, really any news involving infectious disease.

Some useful websites:

* [ProMED-mail](https://www.promedmail.org/)
* [ReliefWeb](https://reliefweb.int/)
* [Precision Vaccinations](https://www.precisionvaccinations.com/)
* [CIDRAP](http://www.cidrap.umn.edu/news-perspective)
* [Outbreak News Today](http://outbreaknewstoday.com/)
* [Contagion Live](http://www.contagionlive.com/)
* [Food Safety News](http://www.foodsafetynews.com/)
* [CDC Current Outbreak List](https://www.cdc.gov/outbreaks/index.html)
* [WHO Disease Outbreak News](http://www.who.int/csr/don/en/)

<div class="md"><p>Infectious Disease News is about any current outbreaks, scientific publications, cases, media stories, press releases, really any news involving infectious disease.</p>

<p>Some useful websites:</p>

<ul>
<li><a href="https://www.promedmail.org/">ProMED-mail</a></li>
<li><a href="https://reliefweb.int/">ReliefWeb</a></li>
<li><a href="https://www.precisionvaccinations.com/">Precision Vaccinations</a></li>
<li><a href="http://www.cidrap.umn.edu/news-perspective">CIDRAP</a></li>
<li><a href="http://outbreaknewstoday.com/">Outbreak News Today</a></li>
<li><a href="http://www.contagionlive.com/">Contagion Live</a></li>
<li><a href="http://www.foodsafetynews.com/">Food Safety News</a></li>
<li><a href="https://www.cdc.gov/outbreaks/index.html">CDC Current Outbreak List</a></li>
<li><a href="http://www.who.int/csr/don/en/">WHO Disease Outbreak News</a></li>
</ul>
</div>

<div class="md"><p>Outbreaks, publications, cases, any infectious disease news.</p>
</div>

21,607 Subscribers

A 22.7% fatality rate for Rwandan Marburg outbreak- a disease that usually kills 90% of patients